MENU
+Compare
SLDB
Stock ticker: NASDAQ
AS OF
Jan 21 closing price
Price
$3.26
Change
-$0.01 (-0.31%)
Capitalization
130.25M

SLDB Solid Biosciences Forecast, Technical & Fundamental Analysis

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SLDB with price predictions
Jan 08, 2025

SLDB's RSI Oscillator climbs out of oversold territory

The RSI Oscillator for SLDB moved out of oversold territory on January 03, 2025. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 48 similar instances when the indicator left oversold territory. In of the 48 cases the stock moved higher. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

The Moving Average Convergence Divergence (MACD) for SLDB just turned positive on January 03, 2025. Looking at past instances where SLDB's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SLDB advanced for three days, in of 220 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on January 07, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SLDB as a result. In of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SLDB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SLDB entered a downward trend on January 08, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.780) is normal, around the industry mean (15.017). P/E Ratio (0.000) is within average values for comparable stocks, (88.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.838). SLDB has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.013). P/S Ratio (0.000) is also within normal values, averaging (265.166).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. SLDB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SLDB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
SLDB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

a developer of novel gene therapy platform for advancing disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
500 Rutherford Avenue
Phone
+1 617 337-4680
Employees
88
Web
https://www.solidbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SAVEQ0.530.03
+5.51%
Spirit Airlines, Inc.
THNPY28.961.08
+3.88%
Technip Energies NV
NVZMY57.221.22
+2.18%
NOVONESIS A S
DNBBY21.120.37
+1.77%
DNB ASA
ASMLF762.25-16.75
-2.15%
ASML Holding N.V.

SLDB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLDB has been loosely correlated with TRDA. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SLDB jumps, then TRDA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLDB
1D Price
Change %
SLDB100%
-0.31%
TRDA - SLDB
42%
Loosely correlated
+2.92%
INZY - SLDB
42%
Loosely correlated
-0.74%
MGTX - SLDB
41%
Loosely correlated
+2.40%
PRME - SLDB
40%
Loosely correlated
+0.69%
ACLX - SLDB
40%
Loosely correlated
+0.14%
More